Androgen receptor-mediated CD8+ T cell stemness programs drive sex differences in antitumor immunity.
Immunity. 2022 Jun 10:S1074-7613(22)00232-1. doi: 10.1016/j.immuni.2022.05.012. Online ahead of print.
Immunity. 2022.
PMID: 35700739